New York, June 24, 2015 -- Moody's Investors Service today affirmed U.S. Renal Care, Inc.'s ("U.S. Renal") B2 Corporate Family Rating and B2-PD Probability of Default Rating. At the same time, Moody's affirmed the Ba3 rating on the company's senior secured credit facilities and Caa1 rating on its senior secured second lien term loan. In addition, Moody's changed the rating outlook to stable from negative.
Vollständigen Artikel bei Moodys lesen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.